Search

Search Constraints

You searched for: Author/Creator Denis, F

Search Results

1. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

2. 1474PNivolumab in non-small cell lung cancer: French evaluation of use, current practices and medico-economic approach. (23rd October 2018)

4. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)